TScan Therapeutics Inc <TCRX.O>: H.C. Wainwright cuts target price to $1 from $7
TCRX•Related News
CoStar sees Canada retail vacancy holding near 2.5% as Hudson’s Bay closures ripple through malls
CSGP•
Labcorp acquires MLM Medical Labs to expand clinical trial central lab network
LH•
Greenland subsidiary HEVI wins New York incentive approval for electric loaders
GTEC•
ExxonMobil unit Pioneer launches cash tender offers for USD 2.1 billion of senior notes due 2030-2031
XOM•
YPF names Martín de los Ríos Plaza to board after Maximiliano D'Alessio resignation
YPF•